Skip to main content
. 2015 Oct 14;6(38):41123–41133. doi: 10.18632/oncotarget.5660

Figure 2. The effects of lapatinib combinations on downstream signaling.

Figure 2

SKBr3 cells were treated with either 200 nM lapatinib alone or in combination with PI3K, AKT, mTor and MEK inhibitors. Cell lysates were collected at 0, 1, 48, 72 hours post-treatment and analyzed by western blotting for phosphorylation of proteins at various signaling nodes downstream of HER2 signaling. Drug concentrations are identical to figure 1.